Vor Biopharma Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Vor Biopharma Inc. reported Cash And Cash Equivalents At Carrying Value of $396.49 million for the year ending 2025.

  • Vor Biopharma Inc. showed an increase of +383.8% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from Vor Biopharma Inc.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
  • XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 6 years of available data (2020 to 2025), Vor Biopharma Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 716.8%.
  • Historical annual values: Fiscal year 2025: $396.49 million | Fiscal year 2024: $81.95 million | Fiscal year 2023: $31.36 million | Fiscal year 2022: $57.71 million | Fiscal year 2021: $119.80 million | Fiscal year 2020: $48.54 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: